SCHEMBL25475400

SCHEMBL25475400

FC(F)(F)c1cccc2[nH]nc(Cl)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.46
▸ GAA P10253 1/20 0.43
▸ NOTUM Q6P988 4/20 0.40
▸ KIF11 P52732 1/20 0.39
▸ KDR P35968 2/20 0.37
▸ GRM4 Q14833 1/20 0.37
▸ CTNNB1 P35222 1/20 0.37
▸ WNT3A P56704 1/20 0.37
▸ TRPA1 O75762 1/20 0.36
▸ TRPM8 Q7Z2W7 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ ABL1 P00519 4/20 0.36
▸ BCR P11274 3/20 0.36
▸ PDPK1 O15530 1/20 0.36
▸ MAP2K4 P45985 2/20 0.35
▸ P2RX7 Q99572 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PAK4 O96013 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13122322 0.79 AXL (0.46) AXLGAANOTUMKIF11KDR
SCHEMBL2660889 0.79 GAA (0.56) AXLGAAKDRABL1BCR
SCHEMBL14631560 0.79 AXL (0.46) AXLGAANOTUMKIF11KDR
SCHEMBL28067226 0.79 AXL (0.46) AXLGAANOTUMKIF11KDR
SCHEMBL13312178 0.73 AXL (0.41) AXLKIF11GRM4CTNNB1WNT3A
Hydrochloric Acid SCHEMBL3501027 0.72 AXL (0.41) AXLKIF11GRM4CTNNB1WNT3A
SCHEMBL11822912 0.72 AXL (0.41) AXLGAANOTUMKIF11KDR
SCHEMBL1172394 0.72 GAA (0.56) AXLGAAKDRABL1PDPK1
SCHEMBL7737026 0.72 GAA (0.47) GAAKDRABL1PDPK1MAP2K4
SCHEMBL23604563 0.72 PDPK1 (0.52) AXLGAAKDRPDPK1MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146829-A1 SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF UNIV TENNESSEE RES FOUND (US) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146829-A1 SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF AR, BRCA1, FSHR AXL 1924/4885GAA 1315/4885NOTUM 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback